Stock NVCT NUVECTIS PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Nuvectis Pharma, Inc.

Equities

NVCT

US67080T1088

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-07-02 EDT 		5-day change 1st Jan Change
6.51 USD +5.34% Intraday chart for Nuvectis Pharma, Inc. -8.31% -21.94%
05-07 Nuvectis Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-08 Nuvectis Pharma's Nxp900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NUVECTIS PHARMA, INC. Stock Nuvectis Pharma, Inc.
 113M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 114B
ARGENX SE Stock argenx SE
 25.71B -
BIONTECH SE Stock BioNTech SE
 19.02B -
GENMAB A/S Stock Genmab A/S
 15.83B
  1. Stock Market
  2. Equities
  3. NVCT Stock
  4. Charts Nuvectis Pharma, Inc.
  5. Sector Chart